ATCC, the world’s premier biological materials management and standards organization, today announced a five-year, $87 million award from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to support the development of next-generation medical countermeasures (MCMs) to protect Americans from public health security threats such as coronaviruses.
FDA lays out cross-agency efforts on regulating AI in medical products
The FDA is spelling out its game plan for regulating artificial intelligence in medical products, according to a paper published Friday. The seven-page report was
March 16, 2024